Optional product analytics
With your permission, we use privacy-limited analytics to understand which research journeys work. We do not run advertising trackers or session replay. You can change this choice in Preferences. Read the Privacy Policy.
Alphabet Inc. Class C's published Reduce conclusion compares the analysis-date price with fair value and potential value. Read the full report for assumptions, evidence, and material risks.
| Market cap | $4.15T | |
|---|---|---|
| Revenue (ttm) | 445.9B | |
| Net income (ttm) | 244.1B | |
| EPS (ttm) | $19.9 | |
| Shares out | 12.2B | |
| P/E (trailing) | 16.1x | |
| P/E (forward) | 22.1x | |
| Dividend | $0.88 (0.27%) | |
| Volume | 17,944,160 | |
| Beta | 1.21 |
Recent price action with selectable time range.
| Item | P1 | P2 | P3 | P4 | P5 | Trend |
|---|---|---|---|---|---|---|
| Period | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | Trend |
| Revenue | $257.64B | $282.84B | $307.39B | $350.02B | $402.84B | +11.8% |
| Gross profit | $146.70B | $156.63B | $174.06B | $203.71B | $240.30B | +13.1% |
| Operating income | $78.71B | $74.84B | $84.29B | $112.39B | $129.04B | +13.2% |
| Net income | $76.03B | $59.97B | $73.80B | $100.12B | $132.17B | +14.8% |
| EPS (diluted) | $5.61 | $4.56 | $5.80 | $8.04 | $10.81 | +17.8% |
| EBITDA | $103.52B | $85.16B | $97.97B | $135.39B | $180.70B | +14.9% |
| R&D | $31.56B | $39.50B | $45.43B | $49.33B | $61.09B | +17.9% |
| SG&A | $13.51B | $15.72B | $16.43B | $14.19B | $21.48B | +12.3% |
Recent company headlines from major financial publishers.
If revenue meets expectations, profit and cash must still follow before the enlarged build creates enough value to change the valuation view.
This case strengthens if FY2027 revenue meets expectations and free cash flow improves despite the spending build. It weakens if higher spending keeps absorbing operating cash.
| Ke ↓ / g → | 2.0% | 2.5% | 3.0% | 3.5% | 4.0% |
|---|---|---|---|---|---|
| 7.9% | $343 | $356 | $371 | $390 | $414 |
| 8.9% | $308 | $317 | $327 | $338 | $353 |
| 9.9% | $282 | $288 | $295 | $303 | $312 |
| 10.9% | $261 | $266 | $270 | $276 | $282 |
| 11.9% | $244 | $248 | $251 | $255 | $259 |
Upcoming earnings date and setup when available.
The rating each month's published research edition carried. A rating compares the price at analysis with the Fair value; it is not a record of whether the call was right.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 |
